Expression analysis of 6p22 genomic gain in retinoblastoma.
about
The human DEK oncogene regulates DNA damage response signaling and repairOverview of recurrent chromosomal losses in retinoblastoma detected by low coverage next generation sequencingMultimodality imaging methods for assessing retinoblastoma orthotopic xenograft growth and developmentIntercellular trafficking of the nuclear oncoprotein DEK.Cdh11 acts as a tumor suppressor in a murine retinoblastoma model by facilitating tumor cell death.Selective roles of E2Fs for ErbB2- and Myc-mediated mammary tumorigenesis.Tuberous sclerosis complex 1 regulates dE2F1 expression during development and cooperates with RBF1 to control proliferation and survival.Genetic and Epigenetic Discoveries in Human RetinoblastomaHigh-affinity interaction of poly(ADP-ribose) and the human DEK oncoprotein depends upon chain length.Control of tumorigenesis and chemoresistance by the DEK oncogeneHigh expression of oncoprotein DEK predicts poor prognosis of small cell lung cancerHuman LSD2/KDM1b/AOF1 regulates gene transcription by modulating intragenic H3K4me2 methylation.The nucleoporin Nup153 affects spindle checkpoint activity due to an association with Mad1.Inactivation of the Rb pathway and overexpression of both isoforms of E2F3 are obligate events in bladder tumours with 6p22 amplification.Cell cycle regulator gene CDC5L, a potential target for 6p12-p21 amplicon in osteosarcomaDEK over expression as an independent biomarker for poor prognosis in colorectal cancer.Melanoma proliferation and chemoresistance controlled by the DEK oncogeneEmerging roles of E2Fs in cancer: an exit from cell cycle controlApoptosis inhibition by the human DEK oncoprotein involves interference with p53 functions.DEK expression in melanocytic lesions.The DEK nuclear autoantigen is a secreted chemotactic factorThe TAg-RB murine retinoblastoma cell of origin has immunohistochemical features of differentiated Muller glia with progenitor properties.The DEK oncoprotein binds to highly and ubiquitously expressed genes with a dual role in their transcriptional regulation.Chromosome 6p amplification and cancer progression.Future directions and treatment strategies for head and neck squamous cell carcinomasMolecular deregulation induced by silencing of the high mobility group protein A2 gene in retinoblastoma cells.Expression level of DEK in chronic lymphocytic leukemia is regulated by fludarabine and Nutlin-3 depending on p53 status.Overexpression of DEK is an indicator of poor prognosis in patients with gastric adenocarcinoma.DEK is a poly(ADP-ribose) acceptor in apoptosis and mediates resistance to genotoxic stressDEK depletion negatively regulates Rho/ROCK/MLC pathway in non-small cell lung cancer.KIF14 and E2F3 mRNA expression in human retinoblastoma and its phenotype association.Overexpression of the cellular DEK protein promotes epithelial transformation in vitro and in vivoThe role of DEK protein in hepatocellular carcinoma for progression and prognosis.Progress in studies on the DEK protein and its involvement in cellular apoptosis.The genomic landscape of retinoblastoma: a review.The DEK oncoprotein and its emerging roles in gene regulation.RB1 gene inactivation by chromothripsis in human retinoblastomamiR-217 inhibits invasion of hepatocellular carcinoma cells through direct suppression of E2F3.A role for intracellular and extracellular DEK in regulating hematopoiesis.Rad18 is a transcriptional target of E2F3.
P2860
Q24306086-2427014B-2CA5-46B5-B6E2-EEB86A248B3FQ26765431-9E03C621-0F5B-41DE-8F4E-3438E0266166Q28539433-13E75706-B1AB-4BE7-8609-DD3346BE549DQ30539239-ABCB238A-51B3-4E19-B618-CC7FDD537D5DQ33565434-2401C3FF-13F1-448F-838C-58C3D42DD84DQ33657413-3F5D461A-1A9A-45DE-9D30-91F0A949AA2BQ33680727-EEAEE75D-1834-429C-84BF-C38F3877A55CQ33763680-9AB89D8E-AA0B-4AEE-A477-38A57BEA5A5DQ34090063-9EA6E406-C0BE-4647-ABCC-28E6E5487D2FQ34096933-19CD5C0D-4F12-4E75-ADF3-8EDBB3B451F1Q34121479-9F15C740-FFE5-4128-A2FE-ADCFC56EBA03Q34128674-C0C3F607-A87C-4CBD-AD28-AC3A259CD9F3Q34558155-A61B7E2C-CDDD-4E44-A4D1-0C4FD5DAB296Q34585359-B187F1EE-E4A8-4717-805D-CA786D6910D1Q34593395-2AF82B7D-DDB7-457F-B394-EC89D33CD4A5Q34884622-6281146A-AB72-481D-9F20-F6643BEE9520Q34997265-49D5BBA4-F478-4286-ABA9-DB0799D7871AQ35009182-825A54CF-E78F-448B-A415-F4479B86C268Q35131718-042C863C-25FD-4377-9398-C1A2AA82B545Q35182702-D32BF033-FDC0-4356-ACFD-28EB1271AD6AQ35221391-131F2C48-B76A-427F-9871-35C5ECF73331Q35247713-6AF1CBDD-6CD1-4C59-BA17-683020992481Q35250786-94ADEAC0-7774-4432-86DB-D407AE156A97Q35770642-B0859587-A21F-4C43-8D68-8B259DDE35AFQ36177257-EC98FF8A-B8A0-42E6-97DA-AA861F611E7AQ36322333-0ABA42B9-B47F-48F4-B0DD-D555C5497301Q36524257-EF264FD7-1E03-4CE2-93E2-327E61BF67D4Q36651966-05204701-4F48-4BA4-8CD4-DF1DD757DB6AQ36710870-27BAD8E5-E61F-4569-9B88-F005FCB73A75Q36999751-D2C033BB-C49D-43D6-9730-816DA76F1F1EQ37078840-9B5A5D43-DB83-46F6-B7FA-AC44042D0EF6Q37116215-636F2A8E-1A44-4342-8AB2-6B08AF2A9B3CQ37258023-8665B570-5493-429A-BCBD-34BD70BC1D5AQ37566333-C2102B5A-B178-4611-8295-BE50B2D7B8BDQ38179069-9BFC6DA0-D6DA-4A7C-BABC-801E3FC6F351Q38375804-AF4B7765-E18C-4ECC-A939-1CFE0A955EADQ38457744-721661B9-5196-43C9-BA10-8719FB906049Q39011414-DFFB5DCF-F588-4C92-89C4-204FB5439431Q39184178-3639F117-13E6-4CA8-9EE2-812243365D71Q39385329-6F513349-599F-435D-9D35-161FC4B71BF4
P2860
Expression analysis of 6p22 genomic gain in retinoblastoma.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Expression analysis of 6p22 genomic gain in retinoblastoma.
@en
type
label
Expression analysis of 6p22 genomic gain in retinoblastoma.
@en
prefLabel
Expression analysis of 6p22 genomic gain in retinoblastoma.
@en
P2093
P356
P1476
Expression analysis of 6p22 genomic gain in retinoblastoma.
@en
P2093
Clarellen E Spencer
Marija Orlic
P2860
P356
10.1002/GCC.20263
P577
2006-01-01T00:00:00Z